Tissue-Engineered “Metastases”: Treatment of Hepatic Colon Tumors with a Dual Action Autotaxin Inhibitor-Lysophosphatidic Acid Receptor Antagonist . J. Can. Res. Updates [Internet]. 2021 Aug. 20 [cited 2026 Jan. 14];1(1):69-77. Available from: https://neoplasiaresearch.com/index.php/jcru/article/view/618